2′, 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
US9108999B2 · kind B2 · utility
7Cited by
11References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2012 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Dec 17, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds of Formula (I): Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of using the compounds of Formula (I) and/or compositions comprising the compounds of Formula (I) for the treatment of HCV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.